Pregabalin Capsule
Product Images NDC 70518-3974

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-3974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description for Pregabalin 25 mg capsules. The package contains 30 capsules and requires a prescription (RX ONLY). The product is manufactured by Amneal Pharma located in Bridgewater, NJ 08807. It should be stored at a temperature of 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701. The expiration date and lot number are not provided in the text. Please refer to the package insert for directions on usage. It is important to keep this medication out of the reach of children.*
FDA Label Image

10 (Pregabalin Capsules 1)

10 (Pregabalin Capsules 1)
FDA Label Image

Lk (Pregabalin Capsules 10)

Lk (Pregabalin Capsules 10)
FDA Label Image

9 (Pregabalin Capsules 11)

9 (Pregabalin Capsules 11)
FDA Label Image

10 (Pregabalin Capsules 12)

10 (Pregabalin Capsules 12)
FDA Label Image

11 (Pregabalin Capsules 13)

11 (Pregabalin Capsules 13)
FDA Label Image

12 (Pregabalin Capsules 14)

12 (Pregabalin Capsules 14)
FDA Label Image

Df (Pregabalin Capsules 2)

Df (Pregabalin Capsules 2)
FDA Label Image

1 (Pregabalin Capsules 3)

1 (Pregabalin Capsules 3)
FDA Label Image

2 (Pregabalin Capsules 4)

2 (Pregabalin Capsules 4)
Not available.*
FDA Label Image

3 (Pregabalin Capsules 5)

3 (Pregabalin Capsules 5)
FDA Label Image

4 (Pregabalin Capsules 6)

4 (Pregabalin Capsules 6)
FDA Label Image

5 (Pregabalin Capsules 7)

5 (Pregabalin Capsules 7)
Percent of Patients Improved: 100 The text mentions the percentage of patients who have shown improvement. The exact nature of this improvement is not specified. Medication Dosage: - Gabapentin: 100 mg three times a day - Pregabalin: 50 mg three times a day - Placebo The dosages of these medications are provided. Graph: The graph provided shows the levels of improvement in pain experienced by patients over time. The x-axis represents different time points (0, 20, 40, 60, 80, 100, 120, 140, 160, 180), and the y-axis indicates the percentage of improvement from the baseline pain level. Overall, this information suggests that a certain percentage of patients experienced improvement in their pain levels while being treated with gabapentin, pregabalin, or a placebo.*
FDA Label Image

6 (Pregabalin Capsules 8)

6 (Pregabalin Capsules 8)
FDA Label Image

7 (Pregabalin Capsules 9)

7 (Pregabalin Capsules 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.